REPORT ID 5372

Global Remicade Biosimilar Market ResearchReport 2019

Publish Date
2019
Pages
107
Format
Electronic (PDF)

In this report, the global Remicade Biosimilar market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Remicade Biosimilar in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Remicade Biosimilar market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Teva Pharmaceutical Industries
    Synthon Pharmaceuticals
    LG Life Sciences
    Novartis (Sandoz)
    Celltrion
    Biocon
    Hospira
    Merck Serono (Merck Group)
    Biogen idec Inc.
    Genentech (Roche Group)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    100mg/10ml
    500mg/50ml
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Blood Disorders
    Oncology Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Remicade Biosimilar Market Research  Report 2019
1 Remicade Biosimilar Market Overview
    1.1 Product Overview and Scope of Remicade Biosimilar
    1.2 Remicade Biosimilar Segment by Type (Product Category)
        1.2.1 Global Remicade Biosimilar Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Remicade Biosimilar Production Market Share by Type (Product Category)  in 2018
        1.2.3 100mg/10ml
        1.2.4 500mg/50ml
    1.3 Global Remicade Biosimilar Segment by Application
        1.3.1 Remicade Biosimilar Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Blood Disorders
        1.3.3 Oncology Diseases
    1.4 Global Remicade Biosimilar Market by Region ( 2014-2024)
        1.4.1 Global Remicade Biosimilar Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Remicade Biosimilar ( 2014-2024)
        1.5.1 Global Remicade Biosimilar Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Remicade Biosimilar Capacity, Production Status and Outlook ( 2014-2024)

2 Global Remicade Biosimilar Market Competition by Manufacturers
    2.1 Global Remicade Biosimilar Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Remicade Biosimilar Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Remicade Biosimilar Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Remicade Biosimilar Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Remicade Biosimilar Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Remicade Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Remicade Biosimilar Market Competitive Situation and Trends
        2.5.1 Remicade Biosimilar Market Concentration Rate
        2.5.2 Remicade Biosimilar Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Remicade Biosimilar Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Remicade Biosimilar Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Remicade Biosimilar Production and Market Share by Region ( 2014-2019)
    3.3 Global Remicade Biosimilar Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Remicade Biosimilar Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Remicade Biosimilar Consumption by Region ( 2014-2019)
    4.2 North America Remicade Biosimilar Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Remicade Biosimilar Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Remicade Biosimilar Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Remicade Biosimilar Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Remicade Biosimilar Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Remicade Biosimilar Production, Consumption, Export, Import ( 2014-2019)

5 Global Remicade Biosimilar Production, Revenue (Value), Price Trend by Type
    5.1 Global Remicade Biosimilar Production and Market Share by Type ( 2014-2019)
    5.2 Global Remicade Biosimilar Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Remicade Biosimilar Price by Type ( 2014-2019)
    5.4 Global Remicade Biosimilar Production Growth by Type ( 2014-2019)

6 Global Remicade Biosimilar Market Analysis by Application
    6.1 Global Remicade Biosimilar Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Remicade Biosimilar Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Remicade Biosimilar Manufacturers Profiles/Analysis
    7.1 Teva Pharmaceutical Industries
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Remicade Biosimilar Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 Synthon Pharmaceuticals
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Remicade Biosimilar Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Synthon Pharmaceuticals Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 LG Life Sciences
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Remicade Biosimilar Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 LG Life Sciences Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Novartis (Sandoz)
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Remicade Biosimilar Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Novartis (Sandoz) Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 Celltrion
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Remicade Biosimilar Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Celltrion Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 Biocon
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Remicade Biosimilar Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Biocon Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 Hospira
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Remicade Biosimilar Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Hospira Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    7.8 Merck Serono (Merck Group)
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Remicade Biosimilar Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Merck Serono (Merck Group) Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.8.4 Main Business/Business Overview
    7.9 Biogen idec Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Remicade Biosimilar Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Biogen idec Inc. Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.9.4 Main Business/Business Overview
    7.10 Genentech (Roche Group)
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Remicade Biosimilar Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Genentech (Roche Group) Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.10.4 Main Business/Business Overview

8 Remicade Biosimilar Manufacturing Cost Analysis
    8.1 Remicade Biosimilar Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Remicade Biosimilar

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Remicade Biosimilar Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Remicade Biosimilar Market Forecast ( 2019-2025)
    12.1 Global Remicade Biosimilar Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Remicade Biosimilar Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Remicade Biosimilar Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Remicade Biosimilar Price and Trend Forecast ( 2019-2025)
    12.2 Global Remicade Biosimilar Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.4 Japan Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.5 Southeast Asia Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.6 India Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
    12.3 Global Remicade Biosimilar Production, Revenue and Price Forecast by Type ( 2019-2025)
    12.4 Global Remicade Biosimilar Consumption Forecast by Application ( 2019-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer